Volume 28, supplement 5, November 2021

ÉDITORIAL

Which one first? (p.5-6)
Laurent Peyrin-Biroulet
Free Access

MINI-REVUES

New therapeutic goals in IBD: STRIDE II (p.7-17)
Catherine Le Berre
Free Access

Anti-integrins in Crohn's disease: What is their place? (p.19-23)
Guillaume Bouguen
Free Access

Management of ulcerative colitis with 5-aminosalicylates failure (p.24-8)
Mathurin Fumery
Free Access

Interest of therapeutic sequencing in the management of IBD (p.29-36)
Xavier Roblin
Free Access

Impact of IBD treatments on anti-SARS-CoV-2 immunity in Covid-19 disease or on vaccine efficacy (p.37-44)
Stéphane Paul
Free Access